Filter
1427
Text search:
drug
approval
Featured
Recommendations
95
New Publications
409
Language
Document type
No document type
838
Studies & Reports
258
Guidelines
180
Manuals
61
Strategic & Response Plan
40
Fact sheets
26
Training Material
15
Resource Platforms
4
Situation Updates
3
Brochures
1
Infographics
1
Countries / Regions
India
93
Global
47
Uganda
43
Kenya
42
Nigeria
37
South Africa
36
Malawi
34
Ethiopia
31
Nepal
28
Western and Central Europe
28
Myanmar / Burma
26
Tanzania
25
Sierra Leone
24
Liberia
23
Ghana
22
Zambia
22
Ukraine
22
Bangladesh
21
Rwanda
20
Namibia
19
Latin America and the Carribbean
18
Lesotho
16
Zimbabwe
14
Africa
14
South–East Asia Region
13
Eastern Europe
12
Botswana
11
Congo, Democratic Republic of
9
Burkina Faso
8
Philippines
8
Cambodia
8
Asia
8
Senegal
7
Thailand
6
Pakistan
5
Syria
5
China
5
Mozambique
5
Benin
5
Tajikistan
5
Russia
5
USA
4
Cameroon
4
South Sudan
4
Indonesia
4
Peru
4
East and Southern Africa
4
Albania
4
Germany
3
Eswatini/ Swaziland
3
West and Central Africa
3
Venezuela
3
Georgia
3
Vietnam
3
Somalia
2
Central African Republic
2
El Salvador
2
Mexico
2
Middle East and North Africa
2
Eastern Europe and Central Asia
2
Bhutan
2
Laos
2
Moldova
2
Jamaica
2
Guinea
1
Iraq
1
Afghanistan
1
Lebanon
1
Sudan
1
Argentina
1
Brazil
1
Colombia
1
Libya
1
Sri Lanka
1
Chile
1
Yemen
1
Western Pacific Region
1
Paraguay
1
Fiji
1
Palestine
1
Armenia
1
Qatar
1
Iran
1
Uzbekistan
1
Kyrgyzstan
1
Australia
1
Kazakhstan
1
North America
1
Turkmenistan
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
629
Clinical Guidelines
118
Public Health
41
Key Resources
38
Women & Child Health
35
Pharmacy & Technologies
33
Capacity Building
13
Toolboxes
HIV
176
TB
134
AMR
102
Mental Health
72
COVID-19
72
Pharmacy
64
NTDs
54
Ebola & Marburg
25
NCDs
24
Rapid Response
22
Caregiver
21
Health Financing Toolbox
17
Planetary Health
16
Malaria
15
Global Health Education
12
Conflict
11
Refugee
11
2.0 Rapid Response
10
Disability
9
Zika
7
Polio
5
Natural Hazards
4
Specific Hazards
4
Cholera
1
Social Ethics
1
National AIDS and STI Control Program
NOVEMBER 2012
This document serves as an update to “Out of the Dark”, a report published by MSF in October 2011, highlighting the need to prioritise the long-neglected area of paediatric tuberculosis (TB). This update will outline the key improvements and setbacks—the ‘highlights’ and ‘
...
IN THE AMOUNT OF SDR 21.8 MILLION (US$30 MILLION EQUIVALENT) WITH AN ADDITIONAL GRANT FROM THE GLOBAL FINANCING FACILITY (GFF) IN THE AMOUNT OF US$ 10 MILLION TO THE DEMOCRATIC REPUBLIC OF CONGO FOR A HUMAN DEVELOPMENT SYSTEMS STRENGTHENING PROJECT
Guidance statement
Recommendations on contraceptive methods used by
women at high risk of HIV
The leishmaniases are a group of diseases caused by Leishmania spp., which occur in cutaneous, mucocutaneous and visceral forms. They are neglected tropical diseases (NTDs), which disproportionately affect marginalized populations who have limited access to health care. HIV co-infected patients with
...
The speed of developing diagnostics for SARS-CoV-2, the causative agent of coronavirus disease 2019 (COVID-19), has been quite remarkable. Diagnostics have focused on nucleic acid amplification testing (NAAT) to identify infected individuals in acute-phase disease for timely implementation of mitiga
...
Project Paper to provide an additional grant for: Human Development Systems Strengthening Project (HDSSP)(P145965, H9360)
To examine how health aid is spent and channelled, including the distribution of resources across countries and between
subsectors. Our aim was to complement the many qualitative critiques of health aid with a quantitative review and to provide insights on the level of development assistance availa
...
Compilation of country case studies and best practices. World Health Report (2010) Background Paper, 25